Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Tiny Implant Treats Sleep Apnea and Snoring

By HospiMedica International staff writers
Posted on 20 Nov 2013
An innovative ultra-small neuromuscular electrical implant stimulates the tongue muscle to treat obstructive sleep apnea (OSA). More...


Developed by researchers at Nyxoah (Brussels, Belgium), the flexible implant is the size of a coin and thinner than a few sheets of paper. The 20 X 2.5 mm implant is designed to be implanted close to the nerves of the tongue muscle by a single small incision performed during a short outpatient procedure. Once placed, the implant does not migrate, and has a lifetime of at least 12 years. Before sleeping, the patient places a disposable adhesive battery patch that wirelessly delivers energy to the implant.

The patch, which measures only 55 x 90 mm, has enough power to wirelessly activate the implant for a full night sleep session, stimulating the tongue throughout the night, completely preventing airway blockage during sleep. The OSA sufferer uses a new disposable patch that has been powered by the charger prior to use. The Nyxoah flexible tongue stimulation implant is a clinical-stage medical device and has been granted eleven US patents for the technology.

“There are many groundbreaking aspects to our solution. Being able to stimulate the tongue muscle all night using a small disposable battery patch is a major innovation,” said Adi Mashiach, MD, co-founder and CEO of Nyxoah, and inventor of the technology. “Our ability to enable minimally invasive implantation in a quick outpatient setting should open the procedure to a significant percentage of the affected population.”

OSA is a sleep disorder characterized by pauses in breathing or instances of shallow or infrequent breathing during sleep. Each pause in breathing (apnea), can last from at least ten seconds to several minutes, and may occur 5-30 times or more an hour. Structural features, low muscle tone, and soft tissue around the airway give rise to the obstructed airway. The risk of OSA rises with increasing body weight, active smoking, and age. In addition, patients with diabetes have up to three times the risk of having OSA.

Related Links:

Nyxoah



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.